Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 3
Submit an article Journal homepage
73
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Combined Fludarabine and Rituximab for Low Grade Lymphoma and Chronic Lymphocytic Leukemia

David G. Savage New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
,
Neil S. Cohen Stamford Hospital, Stamford, CT, USA
,
Charles S. Hesdorffer New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
,
Daniel Heitjan New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
,
Martin W. Oster New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
,
Thomas J. Garrett New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
,
Michael Bar Stamford Hospital, Stamford, CT, USA
,
Salvatore del Prete Stamford Hospital, Stamford, CT, USA
,
Robert March New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
,
Mathew Lonberg New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
,
Susan Talbot New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
,
J. Gregory Mears New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
,
Michael Flamm New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
,
Robert N. Taub New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
&
Gwen Nichols New York Presbyterian Hospital, Columbia Campus, New York, NY 10032, USA
 show all
Pages 477-481 | Published online: 01 Jul 2009

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Hervé Tilly & Andrew Zelenetz. (2008) Treatment of follicular lymphoma: current status. Leukemia & Lymphoma 49:sup1, pages 7-17.
Read now
Mohamed A Kharfan-Dabaja, Rabih Fahed, Mohamad Hussein & Edgardo S Santos. (2007) Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia. Expert Opinion on Investigational Drugs 16:11, pages 1799-1815.
Read now
Piotr Smolewski, Anna Szmigielska-Kaplon, Barbara Cebula, Krzysztof Jamroziak, Małgorzata Rogalinska, Zofia Kilianska & Tadeusz Robak. (2005) Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells. Leukemia & Lymphoma 46:1, pages 87-100.
Read now
Luis Martinez-Lostao, Javier Briones, Monica Martinez-Gallo, Ignasi Forné, Jordi Sierra, Jose Luis Rodriguez-Sanchez & Candido Juarez. (2004) Fludarabine-Induced Apoptosis in CD19+?/CD5+ B-CLL Cells is a Direct and Nurse-Like-Cell Independent Effect. Leukemia & Lymphoma 45:11, pages 2307-2314.
Read now
TADEUSZ ROBAK. (2004) Monoclonal Antibodies in the Treatment of Chronic Lymphoid Leukemias. Leukemia & Lymphoma 45:2, pages 205-219.
Read now

Articles from other publishers (22)

Yosuke Matsumoto, Tsutomu Kobayashi, Yuji Shimura, Eri Kawata, Hisao Nagoshi, Muneo Ohshiro, Mio Sugitani, Kazuho Shimura, Toshiki Iwai, Shin-ichi Fuchida, Mihoko Yoshida, Miki Kiyota, Shinsuke Mizutani, Yoshiaki Chinen, Tomoko Takimoto-Shimomura, Mitsushige Nakao, Hiroto Kaneko, Hitoji Uchiyama, Nobuhiko Uoshima, Hikari Nishigaki, Yutaka Kobayashi, Shigeo Horiike, Chihiro Shimazaki, Masafumi Taniwaki & Junya Kuroda. (2019) Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study. International Journal of Hematology 110:1, pages 77-85.
Crossref
Axel Böhnke & Michael Wenger. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 1909 2022 .
Till SeilerWolfgang HiddemannMartin Dreyling. (2009) Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies. Immunotherapy 1:6, pages 1015-1024.
Crossref
Jennifer R. Brown, Jonathan W. Friedberg, Yang Feng, Sarah Scofield, Kimberly Phillips, Paola Dal Cin, Robin Joyce, Ronald W. Takvorian, David C. Fisher, Richard I. Fisher, Jane Liesveld, Diana Marquis, Donna Neuberg & Arnold S. Freedman. (2009) A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. British Journal of Haematology 145:6, pages 741-748.
Crossref
Steven P. TreonAndrew R. BranaganLeukothea IoakimidisJacob D. SoumeraiChristopher J. PattersonBarry TurnbullParveen WasiChristos EmmanouilidesStanley R. FrankelAndrew ListerPierre MorelJeffrey MatousStephanie A. Gregory & Eva Kimby. (2009) Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia. Blood 113:16, pages 3673-3678.
Crossref
Michael Wenger. 2007. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 1033 1108 .
John D. Roberts, Mitchell R. Smith, Eric J. Feldman, Louise Cragg, Michael M. Millenson, Gail J. Roboz, Connie Honeycutt, Rose Thune, Kristin Padavic-Shaller, W. Hans Carter, Viswanathan Ramakrishnan, Anthony J. Murgo & Steven Grant. (2006) Phase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) Lymphoma. Clinical Cancer Research 12:19, pages 5809-5816.
Crossref
Tadeusz Robak, Piotr Smolewski, Barbara Cebula, Anna Szmigielska‐Kaplon, Krzysztof Chojnowski & Jerzy Z. Blonski. (2006) Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma. Cancer 107:7, pages 1542-1550.
Crossref
Jennifer Long & Linda Versea. (2006) Treatment Approaches and Nursing Considerations For Non-Hodgkin’s Lymphoma. Seminars in Oncology Nursing 22:2, pages 97-106.
Crossref
Tadeusz Robak. (2006) New agents in chronic lymphocytic leukemia. Current Treatment Options in Oncology 7:3, pages 200-212.
Crossref
Nicholas Di Bella & Farhad Ravandi. (2006) Purine Analogue Combinations for Indolent Lymphomas. Seminars in Hematology 43, pages S11-S21.
Crossref
Masataka Ishimura, Shouichi Ohga, Akihiko Nomura, Taikai Toubo, Eiji Morihana, Yusuke Saito, Hisanori Nishio, Makoto Ide, Hidetoshi Takada & Toshiro Hara. (2005) Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation. American Journal of Hematology 80:3, pages 207-212.
Crossref
Eva Kimby. (2005) Tolerability and safety of rituximab (MabThera®). Cancer Treatment Reviews 31:6, pages 456-473.
Crossref
Simon Mantha, Michael I. Jacobs & David G. Savage. (2005) Unusual Leukemia Presentations. Journal of Clinical Oncology 23:24, pages 5841-5843.
Crossref
Gwen L. NicholsDonna L. Skerrett. (2005) Peripheral Blood Stem Cell Mobilization and Harvesting after Fludarabine Therapy for Low-Grade Lymphoma and Chronic Lymphocytic Leukemia. Stem Cells and Development 14:1, pages 3-5.
Crossref
Tadeusz Robak. (2005) Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies. Transfusion and Apheresis Science 32:1, pages 33-44.
Crossref
Tadeusz Robak. (2005) Rituximab Plus Purine Nucleoside Analogs in the Treatment of Indolent Lymphoid Malignancies. American Journal of Cancer 4:5, pages 279-292.
Crossref
Tadeusz Robak. (2005) Therapy of Chronic Lymphocytic Leukaemia with Purine Nucleoside Analogues. Drugs & Aging 22:12, pages 983-1012.
Crossref
Peter H. Wiernik. 2005. 343 389 .
P Kokhaei, A Choudhury, R Mahdian, J Lundin, A Moshfegh, A Österborg & H Mellstedt. (2004) Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL. Leukemia 18:11, pages 1810-1815.
Crossref
Bungo Saito, Tsuyoshi Nakamaki, Daisuke Adachi, Junko Suzuki & Shigeru Tomoyasu. (2004) Acute Respiratory Distress Syndrome during the Third Infusion of Rituximab in a Patient with Follicular Lymphoma. International Journal of Hematology 80:2, pages 164-167.
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:2, pages 91-98.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.